An in vitro co‐culture of MM and NK cells assessed the effects of SMI‐16a (PIM‐2 inhibitor) and ABT888 (PARP1 inhibitor) on tumor proliferation and apoptosis, focusing on DNA damage, MICA expression, and NK cell functionality. The gene discussed is PARP1; the disease is Miyoshi myopathy.